4.5 Article

Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: Success stories from two private pediatric clinics

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Challenges to Adolescent HPV Vaccination and Implementation of Evidence-Based Interventions to Promote Vaccine Uptake During the COVID-19 Pandemic: HPV Is Probably Not at the Top of Our List

Grace Ryan et al.

Summary: The COVID-19 pandemic has negatively affected the promotion of HPV vaccination, resulting in reduced opportunities for vaccination and interruptions in vaccination-related work. Measures need to be taken during the pandemic and further strengthened in the future to ensure the progress of vaccination.

PREVENTING CHRONIC DISEASE (2022)

Article Pediatrics

Coaching and Communication Training for HPV Vaccination: A Cluster Randomized Trial

Melissa B. Gilkey et al.

Summary: This study found that combining quality improvement coaching with remote provider communication training was more effective in improving HPV vaccination uptake compared to quality improvement coaching alone. The combined intervention resulted in consistent improvements across different age groups and vaccination outcomes, while remote communication training alone did not outperform the control group.

PEDIATRICS (2022)

Article Public, Environmental & Occupational Health

National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2021

Cassandra Pingali et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article Obstetrics & Gynecology

Long-Term Multilevel Intervention Impact on Human Papillomavirus Vaccination Rates Spanning the COVID-19 Pandemic

Sharon M. Casey et al.

Summary: This study evaluates the long-term sustainability of a multilevel intervention and the impact of COVID-19 on HPV vaccination coverage among adolescents. The results show that the intervention led to continued improvement in on-time HPV vaccination coverage four years after completion.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2022)

Article Public, Environmental & Occupational Health

Adolescents' Patterns of Well-Care Use Over Time: Who Stays Connected

Kathryn Van Eck et al.

Summary: The study describes longitudinal well-care use patterns from childhood to adolescence, stratified by sex, and identifies different classes of well-care use among adolescents. The findings suggest that sex-specific strategies may be needed to enhance adolescents' well-care use engagement.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2021)

Article Medicine, General & Internal

Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States

Kunal Saxena et al.

Summary: The COVID-19 pandemic has significantly reduced routine vaccine doses administered to US adolescents, with projections suggesting that it will take several years of sustained increase in vaccination rates to recover from the missed doses and mitigate long-term health and economic consequences.

CURRENT MEDICAL RESEARCH AND OPINION (2021)

Review Biotechnology & Applied Microbiology

Non-inferior antibody levels for HPV16/18 after extended two-dose schedules compared with a six-month interval: findings of a systematic review and meta-analysis

Aneisha Collins-Fairclough et al.

Summary: The study found that a 12-month interval for HPV vaccination is non-inferior to a 6-month interval, with inconclusive results for intervals of 36-96 months. This suggests that HPV immunization programs could adopt a 12-month interval to increase flexibility without compromising immunogenicity. Further evaluation is needed to confirm the effectiveness of intervals beyond 12 months.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Biotechnology & Applied Microbiology

Prioritizing and implementing HPV vaccination quality improvement programs in healthcare systems: the perspective of quality improvement leaders

Brigid K. Grabert et al.

Summary: Healthcare systems are crucial partners in implementing HPV vaccination quality improvement programs. While most QI leaders endorse the benefits of HPV vaccination, concerns exist such as small adolescent patient populations, lack of provider buy-in, and competing priorities in health services. Barriers to implementing HPV vaccine QI programs include limited data systems, time constraints, and fee-for-service pressures, while facilitators include automation and passionate vaccine champions.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Pediatrics

Provider Experience Recommending HPV Vaccination Before Age 11 Years

Dea L. Biancarelli et al.

JOURNAL OF PEDIATRICS (2020)

Article Oncology

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation

Debbie Saslow et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Pediatrics

Improving HPV Vaccination Rates: A Stepped-Wedge Randomized Trial

Rebecca B. Perkins et al.

PEDIATRICS (2020)

Article Pediatrics

Parents Who Decline HPV Vaccination: Who Later Accepts and Why?

Melanie L. Kornides et al.

ACADEMIC PEDIATRICS (2018)

Article Medicine, General & Internal

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

Ole-Erik Iversen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Public, Environmental & Occupational Health

Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion

Jennifer L. St Sauver et al.

PREVENTIVE MEDICINE (2016)

Article Public, Environmental & Occupational Health

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices

Elissa Meites et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2016)

Article Oncology

US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines

Mona Saraiya et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Oncology

US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines

Mona Saraiya et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)